K-pop

Ailette of "It's Me" to Release New Album "Break Even" Next Month

New Album After 6 Months… Incheon Concert Also on the Horizon

KIM HYUNSIK
2026-09-14 18:00:57
[Edaily Starin KIM HYUNSIK Reporter] Girl group ILLIT is making a comeback with a new mini-album.
(
Photo
courtesy
of Belief Lab
)
(Photo courtesy of Belief Lab)
According to their agency, Belief Lab, on the 14th, ILLIT will release their fifth mini-album, “BREAK EVEN,” on the 26th of next month.
"BREAK EVEN" marks ILLIT’s comeback six months after the release of their fourth mini-album, "MAMIHLAPINATAPAI," last April. With the title track “It’s Me” from their previous album, Ailette reached No. 38 on the U.S. Billboard Hot 100 and No. 22 on the UK Official Singles Top 100. The song has remained in the top ranks of domestic music charts since its release.
The new album’s title is derived from “break-even point.” Their agency explained, “The album centers on a candid declaration: ‘I will no longer pour my heart and time into relationships that don’t give back as much as I put in.’”
Ailette is currently on their first tour, “PRESS START.” They will meet fans at the Inspire Arena in Incheon on the 17th and 18th of next month.

Economy

Corporation

IT·Science

Economy

"Aftermath of the Jensen Huang Scandal… U.S. to Impose Strict Export Controls on China"

“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
2026-11-13 17:31:12

Corporation

The BORN Korea Reports 3.7 Billion Won Operating Loss in Q3… Deficit Narrows

#The BORN Korea announced on the 13th that it posted a consolidated operating loss of 3.7 billion won in the third quarter of this year. This represents an improvement in the loss compared to the same…
2026-11-13 17:32:49

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02